title: Comparison between the safety profile and clinical results of the Cook detachable and Gianturco coils for transcatheter closure of patent ductus arteriosus in 272 patients.
abstract: OBJECTIVE
  We evaluated the occlusion rate and safety of Cook detachable coils versus Gianturco coils in transcatheter closure of patent ductus arteriosus (PDA).
  
  
  BACKGROUND
  The Cook detachable coil recently was introduced in an attempt to improve the safety of transcatheter closure of PDA.
  
  
  METHODS
  Between January 1994 and September 1998, 272 patients underwent transcatheter PDA closure. Cook detachable coils were used in 137 patients, with a mean age of 43.9 months and weight of 13.8 kg. In 135 patients, Gianturco coils were used, with a mean age of 56.8 months and weight of 17.8 kg. The mean narrowest diameter of the PDA in the Cook detachable coil group was 2.85 mm versus 2.32 mm for the Gianturco coil group.
  
  
  RESULTS
  The Cook detachable coil group was younger and weighed less than the Gianturco group (P < 0.05 and 0.02, respectively). Their narrowest PDA diameter was larger (P < 0.01). Embolization rate was significantly lower in the Cook coil group (9[6.5%] of 137 vs 22 (16.3%) of 135; P = < 0.013). The mean follow-up for the Cook coil group was significantly shorter (0.55 years) than for the Gianturco coil group (1.18 years; P < 0.001). On an intention-to-treat basis, complete occlusion by echocardiography was achieved in 99 (72.3%) of 137 patients in the Cook detachable coil group, which was significantly less than the Gianturco coil group (114 [84.4%] of 135; P = 0.008).
  
  
  CONCLUSIONS
  Cook detachable coils for transcatheter closures of the PDA are safer than Gianturco coils. Hence, children with large ductal can be treated earlier in life. Short-term complete occlusion rate was lower in the Cook detachable coil group. This rate can be explained by a shorter follow-up time, larger ductal diameter, and the different materials used for the detachable coils.
authors.affiliation: Department of Cardiovascular Diseases, MBC 16, King Faisal Specialist Hospital and RC, P.O. Box 3354, Riyadh 11211, Saudi Arabia. ogalal@yahoo.com
authors.forename: M O
authors.initials: MO
authors.lastname: Galal
authors.forename: Z
authors.initials: Z
authors.lastname: Bulbul
authors.forename: A
authors.initials: A
authors.lastname: Kakadekar
authors.forename: A E
authors.initials: AE
authors.lastname: Fatani
authors.forename: M
authors.initials: M
authors.lastname: de Moor
authors.forename: S
authors.initials: S
authors.lastname: el-Oufi
authors.forename: L
authors.initials: L
authors.lastname: Solymar
authors.forename: F
authors.initials: F
authors.lastname: al-Fadley
authors.forename: M E
authors.initials: ME
authors.lastname: Fawzy
mesh_terms: D000293:Adolescent; D000328:Adult; D006328:Cardiac Catheterization / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D004374:Ductus Arteriosus, Patent / Q000628:therapy*; D004621:Embolization, Therapeutic / Q000295:instrumentation*; D004867:Equipment Design; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D019736:Prostheses and Implants / Q000009:adverse effects; D012449:Safety; D016896:Treatment Outcome